TG Therapeutics, Inc.

TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on developing and commercializing novel treatments for B-cell diseases, particularly in the areas of autoimmune disorders like multiple sclerosis (MS) and hematologic malignancies. The company's flagship product, BRIUMVI® (ublituximab-xiiy), is a novel glycoengineered anti-CD20 monoclonal antibody approved by the FDA and the European Commission for the treatment of relapsing forms of MS.

TG Therapeutics also has a robust research pipeline with several investigational medicines, including azer-cel, an investigational anti-CD19 allogeneic CAR T cell therapy, and other compounds targeting various B-cell pathways. The company is committed to developing innovative combination therapies that address the unmet needs of patients with B-cell diseases and is driven by a passion for finding cures.

TG Therapeutics offers a variety of job opportunities with a focus on field-based roles. The company has offices located in Morrisville, NC, New York City, and Edison, New Jersey. For positions like Associate Sales Representatives, travel is required (50+%), and individuals must reside within the assigned geography. The company does not explicitly mention remote or flexible work options on its website.

TG Therapeutics offers a comprehensive benefits package designed to support employee well-being. This includes health insurance plans, dental and vision coverage, life insurance, and disability benefits. The company also provides a 401(k) retirement savings plan with a company match, paid time off, and a generous paid parental leave program. TG Therapeutics prioritizes a work-life balance, promoting employee engagement and professional development through access to professional training and development programs.

TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company dedicated to developing innovative treatments for B-cell diseases. They are committed to leveraging scientific advances in B-cell biology to create novel therapies that improve patient outcomes and offer convenient administration. Their focus is on autoimmune disorders, including multiple sclerosis, as well as B-cell malignancies. TG Therapeutics strives to advance their understanding of these diseases through robust clinical trials and strategic partnerships, while ensuring patient access to their potentially life-changing medicines.

TG Therapeutics cultivates a culture of bold ambition and fearless pursuit, driven by a passion for developing groundbreaking treatments for B-cell diseases. They encourage innovation, collaboration, and a relentless commitment to improving patient outcomes. This strong sense of purpose is evident in their "fiercely focused" message and is fueled by the personal experiences of their team members, many of whom have been directly impacted by these diseases. This personal connection translates into a dedicated and persistent workforce striving to find cures and improve the lives of those affected by B-cell diseases.

TG Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered to contribute their unique talents. The company recognizes the importance of diversity in driving innovation, creativity, and business success. They strive to create an environment that embraces differences, promotes equal opportunities, and provides a sense of belonging for all. TG Therapeutics believes that by cultivating a culture of inclusion, they can attract and retain top talent, enhance collaboration, and ultimately achieve their mission of developing innovative treatments for patients with B-cell diseases.